TrialJournal of hypertension2026

Nebivolol treatment improves hypertension-induced endothelial cell dysfunction by reducing TGF-β1-dependent senescence and normalizing mitochondrial indices.

Paweł Uruski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.